VerifiedBiotechnology Research· Founded 2007

Imaginab

ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products through its proprietary minibody and cys-diabody platforms. The lead candidate 89Zr crefmirlimab berdoxam (CD8 ImmunoPET™) imaging agent is currently in Phase II clinical trials and has been licensed by numerous pharmaceutical and biotech companies for use in imaging within their immunotherapy clinical trials, primarily in oncology.

7-day free trial · no credit card

Inglewood, United States15(11 to 50)$1M to <$10M2007imaginab.com LinkedIn

Verified contacts

13

available on Kipplo

LinkedIn employees

15

11 to 50 range

Open roles

—

no listings

Distinct roles

11

indexed titles

Tech stack

4

tools in use

Monthly traffic

80

organic / mo

Sign up free to see all 13 verified contacts at Imaginab

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

13 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 13 verified contacts

Top roles at Imaginab

11 distinct titles indexed · top 10 shown.

2()
1accounting associate
1cfo
1clinical trial manager
1controller
1director
1project manager
1project manager supply chain management
1senior research associate
1senior scientist
+1more titles

Sign up to unlock all 13 contacts at Imaginab

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 13 verified contacts at Imaginab

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Imaginab | Kipplo Discover